Department of Dermatology, Columbia University, Russ Berrie Medical Science Pavilion, New York, USA.
Carcinogenesis. 2019 Jul 4;40(5):687-694. doi: 10.1093/carcin/bgy168.
Solar UV radiation is a major environmental risk factor for skin cancer. Despite decades of robust and meritorious investigation, our understanding of the mechanisms underlying UV-induced skin carcinogenesis remain incomplete. We previously performed comprehensive transcriptomic profiling in human keratinocytes following exposure to different UV radiation conditions to generate UV-specific gene expression signatures. In this study, we utilized Virtual Inference of Protein Activity by Enriched Regulon (VIPER), a robust systems biology tool, on UV-specific skin cell gene signatures to identify master regulators (MRs) of UV-induced transcriptomic changes. We identified multiple prominent candidate UV MRs, including forkhead box M1 (FOXM1), thyroid hormone receptor interactor 13 and DNA isomerase II alpha, which play important roles in cell cycle regulation and genome stability. MR protein activity was either activated or suppressed by UV in normal keratinocytes. Intriguingly, many of the UV-suppressed MRs were activated in human skin squamous cell carcinomas (SCCs), highlighting their importance in skin cancer development. We further demonstrated that selective inhibition of FOXM1, whose activity was elevated in SCC cells, was detrimental to SCC cell survival. Taken together, our study uncovered novel UV MRs that can be explored as new therapeutic targets for future skin cancer treatment.
太阳紫外线辐射是皮肤癌的一个主要环境风险因素。尽管经过几十年的强有力和卓越的研究,我们对紫外线引起皮肤癌发生的机制的理解仍然不完整。我们之前在人类角质细胞暴露于不同的紫外线辐射条件下进行了全面的转录组分析,以生成紫外线特异性基因表达特征。在这项研究中,我们利用虚拟推理蛋白活性富集调控子(VIPER),一种强大的系统生物学工具,对紫外线特异性皮肤细胞基因特征进行分析,以识别紫外线诱导转录组变化的主要调控因子(MRs)。我们鉴定了多个突出的候选紫外线 MRs,包括叉头框 M1(FOXM1)、甲状腺激素受体相互作用蛋白 13 和 DNA 异构酶 IIα,它们在细胞周期调控和基因组稳定性中发挥重要作用。MR 蛋白活性在正常角质细胞中被紫外线激活或抑制。有趣的是,许多被紫外线抑制的 MRs 在人类皮肤鳞状细胞癌(SCCs)中被激活,突出了它们在皮肤癌发展中的重要性。我们进一步证明,选择性抑制 FOXM1(其活性在 SCC 细胞中升高)对 SCC 细胞的存活有害。总之,我们的研究揭示了新的紫外线 MRs,它们可以作为未来皮肤癌治疗的新治疗靶点进行探索。